+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Nephrostomy Devices Market (2019-2025)

  • ID: 4848996
  • Report
  • Region: North America, United States
  • 76 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Coloplast Group
  • Olympus Corporation
  • Teleflex, Inc.
  • UreSil LLC
  • MORE
The North America Nephrostomy Devices Market is expected to witness market growth of 7.5% CAGR during the forecast period (2019-2025). Due to favorable reimbursement policies, increased product awareness, the accessibility of highly skilled physicians and the involvement of well-established healthcare facilities in the region, it is expected to see significant growth in the future as well. Also, it is expected that the rapid adoption of technologically advanced medical products will drive the region's market. Increasing government funding for R&D activities in surgical devices as well as procedures also have a positive impact on regional market growth.

Over the past few years, percutaneous nephrostomy (PCN) processes have become immensely popular as they eliminate the need for nephrostomy tube or ureteral stent devices. The PCN procedure delivers various benefits, including minimal blood loss; low treatment costs, and prevents leakage of urine. These processes minimize stay in the hospital, create smaller incisions, and guarantee a quicker recovery. As a result, the increasing popularity of percutaneous nephrostomy (PCN) processes during the forecast period will boost the demand for nephrostomy machines.

Based on Product, the market is segmented into Guidewires, Sheath Dilators, Nephrostomy Catheters, Drainage Tubes and Other Nephrostomy Devices. Based on End Use, the market is segmented into Hospital, Ambulatory Surgical Centers (ASCs) and Emergency Clinics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.

Scope of the Study

Market Segmentation:

By Product
  • Guidewires
  • Sheath Dilators
  • Nephrostomy Catheters
  • Drainage Tubes
  • Other Nephrostomy Devices
By End Use
  • Hospital
  • Ambulatory Surgical Centers (ASCs)
  • Emergency Clinics
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Boston Scientific Corporation
  • Teleflex, Inc.
  • Cook Medical, Inc. (Cook Group)
  • Coloplast Group
  • Olympus Corporation
  • Argon Medical Devices, Inc.
  • UreSil LLC
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Becton, Dickinson and Company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Coloplast Group
  • Olympus Corporation
  • Teleflex, Inc.
  • UreSil LLC
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Nephrostomy Devices Market, by Product
1.4.2 North America Nephrostomy Devices Market, by End Use
1.4.3 North America Nephrostomy Devices Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition: 2019-May-2015-Mar) Leading Players

Chapter 4. North America Nephrostomy Devices Market by Product
4.1 North America Guidewires Market by Country
4.2 North America Sheath Dilators Market by Country
4.3 North America Nephrostomy Catheters Market by Country
4.4 North America Drainage Tubes Market by Country
4.5 North America Other Nephrostomy Devices Market by Country

Chapter 5. North America Nephrostomy Devices Market by End Use
5.1 North America Hospital Market by Country
5.2 North America Ambulatory Surgical Centers (ASCs) Market by Country
5.3 North America Emergency Clinics Market by Country

Chapter 6. North America Nephrostomy Devices Market by Country
6.1 USA Nephrostomy Devices Market
6.1.1 USA Nephrostomy Devices Market by Product
6.1.2 USA Nephrostomy Devices Market by End Use
6.2 Canada Nephrostomy Devices Market
6.2.1 Canada Nephrostomy Devices Market by Product
6.2.2 Canada Nephrostomy Devices Market by End Use
6.3 Mexico Nephrostomy Devices Market
6.3.1 Mexico Nephrostomy Devices Market by Product
6.3.2 Mexico Nephrostomy Devices Market by End Use
6.4 Rest of North America Nephrostomy Devices Market
6.4.1 Rest of North America Nephrostomy Devices Market by Product
6.4.2 Rest of North America Nephrostomy Devices Market by End Use

Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Collaborations, partnerships and agreements:
7.1.5.2 Acquisition and mergers:
7.1.5.3 Product launches:
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Expansions:
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Collaborations, partnerships and agreements:
7.3.2.2 Product launches:
7.3.2.3 Expansions:
7.4 Coloplast Group
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.5 Olympus Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Product launches:
7.5.5.3 Acquisition and mergers:
7.6 Argon Medical Devices, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisition and mergers:
7.7 UreSil LLC
7.7.1 Company Overview
7.8 B. Braun Melsungen AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Acquisition and mergers:
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Collaborations, partnerships and agreements:
7.9.4.2 Product launches:
7.1 Becton, Dickinson and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Boston Scientific Corporation
  • Teleflex, Inc.
  • Cook Medical, Inc. (Cook Group)
  • Coloplast Group
  • Olympus Corporation
  • Argon Medical Devices, Inc.
  • UreSil LLC
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Becton, Dickinson and Company
Note: Product cover images may vary from those shown
Adroll
adroll